📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers (2023)

First Author: McCann N
Attributed to:  Development of a Live Attenuated Vaccine Against Salmonella Paratyphi (VASP) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-068966

Publication URI: http://dx.doi.org/10.1136/bmjopen-2022-068966

Type: Journal Article/Review

Parent Publication: BMJ Open

Issue: 5